[Prognostic value of body composition in oncological visceral surgery].

Chirurgie (Heidelberg, Germany) Pub Date : 2024-10-29 DOI:10.1007/s00104-024-02189-5

Saleem Elhabash, Nils Langhammer, Ulrich Klaus Fetzner, Jan-Robert Kröger, Ioannis Dimopoulos, Nehara Begum, Jan Borggrefe, Berthold Gerdes, Alexey Surov

{"title":"[Prognostic value of body composition in oncological visceral surgery].","authors":"Saleem Elhabash, Nils Langhammer, Ulrich Klaus Fetzner, Jan-Robert Kröger, Ioannis Dimopoulos, Nehara Begum, Jan Borggrefe, Berthold Gerdes, Alexey Surov","doi":"10.1007/s00104-024-02189-5","DOIUrl":null,"url":null,"abstract":"<p><p>Screening of nutritional status of cancer patients plays a crucial role in the perioperative management and is mandatory for the certification of oncological centers by the German Cancer Society (DKG). The available screening tools do not differentiate between muscle and adipose tissue. Recent advances in computed tomography (CT) and magnetic resonance imaging (MRI) as well as the automatic picture archiving communication system (PACS) imaging analysis by high performance reconstruction systems have recently enabled a detailed analysis of adipose tissue and muscle quality. Rapidly growing evidence shows that body composition parameters, especially reduced muscle mass, are associated with adverse outcomes in cancer patients and have been reported to negatively affect overall survival (OS), disease-free survival (DFS), toxicity associated with chemotherapy and surgical complications. In this article, we summarize the recent literature and present the clinical influence of body composition in oncological visceral diseases.</p>","PeriodicalId":72588,"journal":{"name":"Chirurgie (Heidelberg, Germany)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chirurgie (Heidelberg, Germany)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00104-024-02189-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Screening of nutritional status of cancer patients plays a crucial role in the perioperative management and is mandatory for the certification of oncological centers by the German Cancer Society (DKG). The available screening tools do not differentiate between muscle and adipose tissue. Recent advances in computed tomography (CT) and magnetic resonance imaging (MRI) as well as the automatic picture archiving communication system (PACS) imaging analysis by high performance reconstruction systems have recently enabled a detailed analysis of adipose tissue and muscle quality. Rapidly growing evidence shows that body composition parameters, especially reduced muscle mass, are associated with adverse outcomes in cancer patients and have been reported to negatively affect overall survival (OS), disease-free survival (DFS), toxicity associated with chemotherapy and surgical complications. In this article, we summarize the recent literature and present the clinical influence of body composition in oncological visceral diseases.

查看原文本刊更多论文

[肿瘤内脏手术中身体成分的预后价值]。

癌症患者的营养状况筛查在围手术期管理中起着至关重要的作用，也是德国癌症协会（DKG）认证肿瘤中心的必备条件。现有的筛查工具无法区分肌肉和脂肪组织。最近，计算机断层扫描（CT）和磁共振成像（MRI）技术的进步，以及通过高性能重建系统进行的自动图像存档通信系统（PACS）成像分析，使得对脂肪组织和肌肉质量的详细分析成为可能。越来越多的证据表明，身体成分参数，尤其是肌肉质量的降低，与癌症患者的不良预后有关，并已报道会对总生存期（OS）、无病生存期（DFS）、化疗相关毒性和手术并发症产生负面影响。在本文中，我们总结了近期的文献，并介绍了身体成分对肿瘤内脏疾病的临床影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chirurgie (Heidelberg, Germany)

自引率

0.00%

发文量